Back to results
US 2016/0289245 A1Published application
Crystalline Beta-Lactamase Inhibitor
AssigneeAllecra Therapeutics SAS
InventorsAlessandro Lamonica, Marco Forzatti, Stefano Biondi
Life of this patent
Estimating the term…
Abstract
A crystalline compound of formula (I): The compound of formula (I) is a β-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
Claims30
A crystalline compound of formula (I):
A process for preparing a crystalline compound of formula (I):
- the process comprising the steps of:
- forming a formulation by dissolving or suspending an amorphous compound of formula (I) in a solvent or solvent mixture;
- and
- crystallizing the compound of formula (I) from the formulation.
1 more element
23-31. (canceled)
(canceled)
Dependencies are inferred from the claim text.